User profiles for Stefano Govoni

Stefano Govoni

Pharmacology professor, Pavia University
Verified email at unipv.it
Cited by 19106

[HTML][HTML] Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2

…, F Fagiani, M Racchi, E Corsini, S Govoni… - Signal transduction and …, 2020 - nature.com
To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19 and
the current standard care relies on supportive treatments. Therefore, based on the fast and …

Wild-type huntingtin protects from apoptosis upstream of caspase-3

…, Y Li, JK Cooper, CA Ross, S Govoni… - Journal of …, 2000 - Soc Neuroscience
Expansion of a polyglutamine sequence in the N terminus of huntingtin is the gain-of-function
event that causes Huntington's disease. This mutation affects primarily the medium-size …

[HTML][HTML] Molecular regulations of circadian rhythm and implications for physiology and diseases

…, L Di Cesare Mannelli, M Racchi, S Govoni… - … and Targeted Therapy, 2022 - nature.com
The term “circadian rhythms” describes endogenous oscillations with ca. 24-h period associated
with the earth’s daily rotation and light/dark cycle. Such rhythms reflect the existence of …

Microbiota and metabolic diseases

…, N Marchesi, C Marelli, A Coppola, L Luzi, S Govoni… - Endocrine, 2018 - Springer
The microbiota is a complex ecosystem of microorganisms consisting of bacteria, viruses,
protozoa, and fungi, living in different districts of the human body, such as the gastro-enteric …

Acetylcholinesterase inhibitors: novel activities of old molecules

…, M Mazzucchelli, E Porrello, C Lanni, S Govoni - Pharmacological …, 2004 - Elsevier
The therapeutic approach for improving the cognitive function in patients with Alzheimer’s
disease (AD) is mainly based on the potentiation of central cholinergic activity and is achieved …

The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases

A Pascale, N Marchesi, S Govoni, A Coppola… - Current opinion in …, 2019 - Elsevier
There is a recent growing evidence that abnormalities in the microbiota composition can
have a major role in the development of obesity and diabetes and that some actions of …

Cognition enhancers between treating and doping the mind

…, I Del Vecchio, M Racchi, F Pistoia, S Govoni - Pharmacological …, 2008 - Elsevier
Memory, attention and creativity represent three different cognitive domains, which are
interconnected and contribute the “mental performance” of an individual. Modern neuroscience …

[HTML][HTML] Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under …

M Amadio, S Govoni, A Pascale - Pharmacological research, 2016 - Elsevier
Roughly ten years ago the FDA approved most of the presently used anti-VEGF drugs for
the treatment of neovascular AMD and other eye pathologies characterized by ocular …

Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase‐dependent pathway

…, M Sironi, C Bonfini, SB Solerte, S Govoni… - The FASEB …, 2000 - Wiley Online Library
Several lines of biochemical evidence correlate the presence of energy metabolic defects
with the functional alterations associated with brain aging and with the pathogenesis of …

In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee

…, M Racchi, A Papetti, C Lanni, S Govoni… - Journal of Agricultural …, 2004 - ACS Publications
The specific antiradical activity against the hydroxyl radical of the water soluble components
in green and dark roasted Coffea arabica and Coffea robusta coffee samples, both in vitro …